Literature DB >> 16855914

Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.

S Yoshida1, M Maeda, S Kaku, H Ikeya, K Yamada, S Nakaike.   

Abstract

It has been pointed out that hyperphosphorylation of microtubule-associated protein tau caused by stress might participate in the early stages of Alzheimer's disease pathogenesis. In the present study, we investigated the effects of cold water stress (CWS) on tau phosphorylation in the mouse hippocampus and the effects of GSK-3beta inhibitor, LiCl, on CWS-induced changes in tau phosphorylation levels by immunoblot analyses. CWS exposure caused an increase in tau phosphorylation at the Tau-1 (Ser199/202), AT8 (Ser202/Thr205) and Ser396 sites. CWS-induced changes in tau phosphorylation at the Ser199/202 and Ser396, but not at Ser202/Thr205, were significantly attenuated by LiCl pretreatment. Total tau levels also showed a decided tendency to increase after CWS, which tendency was also countered by LiCl. Finally, we showed that CWS increased the active form of GSK-3beta that was phosphorylated at Tyr216. These results suggest that a CWS-induced increase in phosphorylated tau in the hippocampus is mediated, at least partly, by the activation of GSK-3beta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855914     DOI: 10.1007/s00702-006-0528-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  33 in total

1.  Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.

Authors:  C X Gong; T Lidsky; J Wegiel; L Zuck; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

Authors:  Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Hiroyuki Arai; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Frank Padberg; Frank Faltraco; Alexander Goernitz; Tero Tapiola; Stanley I Rapoport; Tuula Pirttilä; Hans-Jürgen Möller; Harald Hampel
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

3.  The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Authors:  G Chen; L D Huang; Y M Jiang; H K Manji
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

4.  Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.

Authors:  E Planel; K Yasutake; S C Fujita; K Ishiguro
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

5.  The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

Authors:  Karelle Leroy; Allal Boutajangout; M Authelet; James R Woodgett; Brian H Anderton; Jean-Pierre Brion
Journal:  Acta Neuropathol       Date:  2001-11-29       Impact factor: 17.088

6.  Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.

Authors:  Pedro J Modrego; Jaime Ferrández
Journal:  Arch Neurol       Date:  2004-08

7.  Stress induces activation of stress-activated kinases in the mouse brain.

Authors:  Ya Fang Liu; Kurt Bertram; George Perides; Bruce S McEwen; Dechun Wang
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

8.  Stress-induced hyperphosphorylation of tau in the mouse brain.

Authors:  Yasuhiro Okawa; Koichi Ishiguro; Shinobu C Fujita
Journal:  FEBS Lett       Date:  2003-01-30       Impact factor: 4.124

9.  Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

Authors:  Patrizia De Sarno; Xiaohua Li; Richard S Jope
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

10.  Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.

Authors:  Chang-peng Shen; Yelena Tsimberg; Christopher Salvadore; Emanuel Meller
Journal:  BMC Neurosci       Date:  2004-09-20       Impact factor: 3.288

View more
  4 in total

1.  Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.

Authors:  Shannon N Campbell; Cheng Zhang; Louise Monte; Allyson D Roe; Kenner C Rice; Yvette Taché; Eliezer Masliah; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation.

Authors:  Robert A Rissman; Kuo-Fen Lee; Wylie Vale; Paul E Sawchenko
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

3.  Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models.

Authors:  Thomas Kramer; Boris Schmidt; Fabio Lo Monte
Journal:  Int J Alzheimers Dis       Date:  2012-07-22

Review 4.  Tauopathy and neurodegeneration: A role for stress.

Authors:  Jorge A Sierra-Fonseca; Kristin L Gosselink
Journal:  Neurobiol Stress       Date:  2018-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.